AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (3571 Reviews)

KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.

Harshit Chawla

Harshit Chawla

Insurance Advisor

Investing used to confuse me, but KSquare simplified everything. Their recommendations are tailored and backed by data. It’s been a smooth and rewarding ride so far.

Aditi Rane

Aditi Rane

Communications Officer

I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!

Ishita Mehra

Ishita Mehra

Research Associate

I used KSquare to meet some short-term needs, and their loan against mutual funds service was quick and easy.

Arjun Khanna

Arjun Khanna

Business Analyst

Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.

Sneha Kulkarni

Sneha Kulkarni

Healthcare Administrator

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

I started my NPS with KSquare last year, and the process was very smooth. I trust them with long-term goals.

Deepika Menon

Deepika Menon

Digital Marketer

KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.

Rohit Sharma

Rohit Sharma

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

Thanks to KSquare, I can now invest in India confidently from the US. Their team was extremely helpful and always available when I had questions.

Varun Iyer

Varun Iyer

Finance Manager

FAQ's

Frequenlty Asked Question

How is SIP different from recurring deposits?

Unlike fixed-interest recurring deposits, SIP returns are market-linked and offer higher growth potential with some risk.

How does KSquare help with mutual fund selection?

KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.

Does KSquare provide regular portfolio updates?

Yes, clients receive consistent performance updates and guidance, ensuring investments remain aligned with goals at every stage.

What is the minimum amount to start investing with KSquare?

NRIs can begin with as little as ₹1,000 per month depending on the investment vehicle, offering flexible entry points.

How secure is KSquare’s platform for NRI users?

KSquare uses encrypted systems, regulatory safeguards, and secure servers to protect user data and transactions.

How do I repay the loan taken against mutual funds?

You can repay the loan in EMIs or lump sum, as per the agreed terms. KSquare offers reminders and easy tracking.

What are the tax benefits of NPS?

NPS offers deductions up to ₹1.5 lakh under Section 80C and an additional ₹50,000 under Section 80CCD(1B) of the Income Tax Act.

Will I get tax benefits through SIP investments?

Yes, SIPs in ELSS funds qualify for tax deductions under Section 80C up to ₹1.5 lakh annually.

App Store